RAZA SAIYED ATIQ 4
4 · Arteris, Inc. · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Arteris (AIP) Director Raza Saiyed Atiq Sells Shares
What Happened
Raza Saiyed Atiq, a director of Arteris, sold a total of 90,279 shares of Arteris common stock in open-market transactions between Feb 25–27, 2026, generating approximately $1,545,259 in proceeds. The individual trades reported were:
- 2/25/2026: 4,907 shares at $17.00 — $83,419
- 2/26/2026: 73,610 shares at a weighted average $17.14 — $1,261,793
- 2/27/2026: 11,762 shares at $17.01 — $200,047
These were sales (not purchases) and therefore typically represent liquidity or portfolio management rather than a buy signal.
Key Details
- Transaction type: Open-market sales (Code S). Total sold: 90,279 shares for ~$1,545,259.
- Dates and price notes:
- 2/25/2026 — sold at $17.00 (single price).
- 2/26/2026 — weighted average $17.14; actual prices ranged $17.00–$17.01 (footnote F2).
- 2/27/2026 — weighted average $17.01; related sales ranged $17.00–$17.05 or up to $17.25 in portions per footnotes (F4, F5); weighted averages reported.
- Footnotes of interest:
- F1: Sales were made under a 10b5-1 trading plan adopted Nov 7, 2025 (pre-set trading plan).
- F3: Shares are held by the "Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust," for which he serves as trustee.
- F2/F4/F5: Prices shown are weighted averages; the filer can provide a breakdown of prices on request.
- Shares owned after the transactions: Not specified in the provided Form 4 excerpt.
- Filing timeliness: Form 4 was filed Feb 27, 2026; transactions occurred Feb 25–27, 2026. The filing date appears within the typical two-business-day reporting window and is not marked as late.
Context
Sales executed under a 10b5-1 plan are pre-arranged and are generally intended to avoid trading on inside information; they are common for insiders seeking planned liquidity. These are outright sales (not option exercises or gifts) and do not by themselves indicate management’s view of the company’s prospects.
Insider Transaction Report
Form 4
RAZA SAIYED ATIQ
Director
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-02-25$17.00/sh−4,907$83,419→ 585,093 total(indirect: By Trust) - Sale
Common Stock
[F1][F4][F3]2026-02-26$17.14/sh−73,610$1,261,793→ 511,483 total(indirect: By Trust) - Sale
Common Stock
[F1][F5][F3]2026-02-27$17.01/sh−11,762$200,047→ 499,721 total(indirect: By Trust)
Holdings
- 20,839
Common Stock
Footnotes (5)
- [F1]Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.01 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.
- [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.25 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.05 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Paul Alpern, as Attorney-in-Fact for S. Atiq Raza|2026-02-27